The European Master in Clinical Linguistics (EMCL) is an Erasmus Mundus Joint Master’s Degree (EMJMD) that has been running for over twenty years. The newest edition is offered by Ghent University Ghent (Belgium), the University of Groningen (The Netherlands) and the University of Eastern Finland (Finland). We also collaborate with twenty-six excellent associated partners.
At the University of Groningen the emphasis is on crosslinguistic studies of language-impaired children and adults, language testing in neurosurgical settings, and the usage of neurotechnology and IT for the diagnosis and treatment of language impairments. At Ghent University students are familiarised with advanced topics in statistics and psycholinguistics, including bilingualism, dyslexia, and eye tracking. Finally, at the University of Eastern Finland, the main focus is on speech technology and programming with Python, including both fundamental theory and methods, as well as their application to the assessment of, and adaptive solutions for, speech impairments.
In addition, we have the support of twenty-six associated partners, of which twelve are in the academic sector, five in R&D/neurotechnology, and nine in the clinical sector - for further details, take a look at this overview.
In every cohort, we welcome about twenty students from all over the world. Staggered across two years, our students receive training at each of the academic partners, do a mandatory work placement at one of the associated partners, and write an original Master’s dissertation. After graduation, 70% of our students continue to do research in PhD programmes. Since 2017, we have furthermore seen an increasing number of our alumni pursue R&D and clinical careers, making our programme competitive on the international market.